KBLB - Kraig Biocraft Laboratories, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD

Kraig Biocraft Laboratories, Inc.

2723 South State Street
Suite 150
Ann Arbor, MI 48104
United States

SectorBasic Materials
IndustrySpecialty Chemicals
Full Time Employees9

Key Executives

NameTitlePayExercisedYear Born
Mr. Kim K. ThompsonFounder, Chairman, CEO, Pres & CFO457.58kN/A1961
Mr. Jonathan R. RiceCOO & Director162.28kN/A1980
Dr. Trevor L. KaneChief Scientist & Member of Scientific Advisory BoardN/AN/AN/A
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Kraig Biocraft Laboratories, Inc. focuses on developing protein based fibers using recombinant DNA technology for commercial applications in the technical textile and specialty fiber industries in the United States. The company's products are used in military and police applications for ballistic protection; industrial applications, including critical cables and abrasion/impact resistant components; safety equipment; and composite materials for the aerospace industry. Its products are also used in various markets, such as medical textiles, geotextiles, defense and military textiles, safe and protective clothing, filtration textiles, composites with textile structure, and functional and sportive textiles, as well as textiles used in buildings and transportation. Kraig Biocraft Laboratories, Inc. was founded in 2006 and is headquartered in Ann Arbor, Michigan.

Corporate Governance

Kraig Biocraft Laboratories, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.